Dyspareunia and Sexual Dysfunction After Transvaginal Specimen Extraction — A Systematic Review
Across 30 studies and 2,488 women, transvaginal specimen extraction showed low rates of postoperative dyspareunia and no clinically meaningful decline in sexual function scores.
Journal: Journal of Gynecology Obstetrics and Human Reproduction | Published: 2026-03-18 | Type: Systematic Review | PMID:41856315Authors: Kaya C et al. (Istanbul Aydin University; Istanbul Istinye University; Acibadem Kartal Hospital; Hashemite University; Hamad Medical Corporation; Kuwait University)
Funding/COI: Funding not disclosed; authors declare no competing interests
Summary
Transvaginal specimen extraction — removing surgical specimens through the vagina rather than an abdominal incision — has raised concern about postoperative sexual morbidity. This systematic review aggregated 30 studies across general surgery, gynecology, and urology to assess whether that concern is supported by data. The short answer: mostly no, though the urology subgroup is too small to say much with confidence.
Claims
General surgery (1,062 patients): Hybrid NOTES cholecystectomy via transvaginal extraction — dyspareunia was uncommon postoperatively; validated questionnaire scores showed no clinically meaningful decline in sexual function
Gynecology (1,361 patients): Posterior colpotomy for adnexal mass or myomectomy retrieval — very low rates of dyspareunia; no significant difference in validated sexual-function scales compared to conventional laparoscopic approaches
Urology (65 patients): Transvaginal extraction following nephrectomy or renal cyst surgery — no postoperative dyspareunia reported; sexual-function scores remained stable
Overall conclusion: vaginal tissue extraction or NOTES can be performed with low risk of sexual dysfunction or dyspareunia
Study Quality
Three independent reviewers assessed included studies using the Cochrane RoB-2 tool for RCTs and ROBINS-E for non-randomized studies — methodologically appropriate given the mixed study designs. The multi-database search (EBSCOhost, MEDLINE, EMBASE, Cochrane, PubMed), searched May 2025, suggests reasonable comprehensiveness. Use of validated sexual-function questionnaires across most included studies is a genuine strength; generic endpoint reporting would have been far weaker.
That said, the review is narrative rather than pooled — heterogeneity in surgical technique, patient population, follow-up duration, and outcome instruments likely precluded meta-analysis. Without pooled effect sizes and confidence intervals, the reassuring conclusion rests on qualitative aggregation of study-level findings, which is softer evidence than it sounds.
Red Flags
Urology subgroup is vestigial: 65 patients across kidney surgery studies — far too small to draw conclusions about sexual outcomes in that population; the review's scope arguably shouldn't include it
Funding undisclosed: "Not listed" is different from "no funding" — could indicate industry support for a technique whose adoption benefits device or training markets
Follow-up duration not standardized: Dyspareunia and sexual dysfunction after vaginal surgery can manifest or resolve over months; short follow-up would systematically undercount late complications
Heterogeneous definitions: Dyspareunia as reported across 30 studies from multiple specialties almost certainly varies in how it's elicited and graded
Comparison groups inconsistent: The gynecology subgroup had conventional laparoscopy comparators; general surgery and urology largely did not — limits cross-specialty comparisons
No data on women who became sexually inactive postoperatively: If sexual inactivity increased post-surgery, those women drop out of dyspareunia calculations, creating a denominator problem
Strengths
Broad multi-database systematic search with a clear cutoff date
Three independent reviewers applying validated bias-assessment tools
Subgroup analysis by specialty is clinically sensible — these are anatomically and technically different operations
Emphasis on validated sexual-function scales rather than informal symptom reporting
Total sample of 2,488 is meaningful for a condition where individual studies are often small
Verdict
This review does useful consolidation work: it brings together a scattered literature on a real clinical concern and applies appropriate bias-assessment tools. The finding that transvaginal extraction doesn't appear to consistently harm sexual function is reassuring, and the gynecology subgroup — the largest and best-controlled — makes the strongest case. But the absence of pooled statistics, the undisclosed funding, and the 65-patient urology subgroup limit how far that reassurance travels. It's a reasonable starting point for surgical decision-making conversations, not a definitive safety verdict.